Current Events

The Organic Reaction catalysis Society seeks to advance the practical application of catalysis . The conference will have symposia on C-C coupling, Chemicals from Biorenewable Feedstocks, and hydrogenation. Matthias Beller, and Hans-Ulrich Blaser will receive awards and are featured speakers. Registration is online at www.orcs.org

The aim of the conference is to cover recent developments in the area of semiconductor photochemistry. The topics will encompass: * Solar to Electricity conversion (DSSCs) and Tandem Cells * Solar to Chemical Energy conversion (such as water splitting and CO2 reduction) * Photosterilisation * Organic Photosynthesis * Air and Water Remediation * Self Cleaning Surfaces

In the life-cycle of biopharmaceuticals, manufacturing change is unavoidable. Owing to the complex nature of the biopharmaceutical product, physicochemical and functional changes occur which can affect both safety and efficacy. This three-track event looks at manufacturing change and its potential consequences, and industry experiences with handling this and harnessing it to advantage. Conferences Include: Protein Scale-Up, Process Change & Technology Transfer, Post-translational Modifications, Comparability at all Stages of Development

Fixed-Dose and Co-Packaged Combinations provide novel business opportunities for companies to leverage their existing portfolio of products and intellectual property in addition to providing avenues for strategic partnership with other companies. However, they also offer unique development, regulatory, and commercial challenges. This conference will focus on the practical interplay between combination therapy forefront research, development challenges, and commercial and partnering strategies, as well as the implications for successful market realization.

Recognizing increasing needs in new materials and applications of pervaporation, vapor permeation and membrane distillation processes, Membrane Separation Processes Research Group from Nicolaus Copernicus University (Toruń, Poland) decided to organize in April 2010 International Conference on Pervaporation and Vapor Permeation. Conference Topics to be Covered: 1. Fundamentals of pervaporation, vapor permeation and membrane distillation processes. 2. New membrane materials (polymeric/inorganic). 3. Applications: · dehydration, removal of organics from water, organic-organic separation; · large scale applications, hybrid industrial operations including PV/VP; · membrane distillation; · small scale and niche applications. 4. Environmental impact and economics of industrial plants.

This new forum focused on future molecular diagnostics will highlight innovative platforms, novel chemistry, and latest approaches to developing sensitive detection of analytes. This meeting is designed to be the premier think tank for building future diagnostics platforms and a forum for presenting new papers. There will be ample discussion around moving novel diagnostics to the clinic and strategies for success.

Conference Programs Include: Resistance is Futile: The Challenge of Antibacterial Drug, Development Integrating Chemistry and Biology, Fragment-Based Drug Discovery, Anti-inflammatories: Small Molecule Approaches, HCV Drug Discovery, Directly targeting viral and host proteins necessary for HCV infection, Kinase Inhibitor Chemistry – Charting the Chemical Space, Protein-Protein Interactions as Drug Targets

The ‘EUCHEM Conference on Stereochemistry’, better known as ‘Bürgenstock Conference’, is an outstanding international chemistry meeting of high scientific quality, with an optimal setting for intense inter-disciplinary discussion. Stereochemistry is the principle underlying our understanding of the processes of life and the properties of matter at the molecular level. It is a key element not only in all chemical disciplines, but also in modern molecular biology, molecular medicine, biophysics, and material design. Accordingly, the ‘Bürgenstock Conference’ has grown over the years into a multi-disciplinary conference where frontier science is being discussed. Lectures cover many areas of chemistry and relevant highlights from neighboring disciplines..

Over 400 thought leaders from 200+ organizations, representing 21 countries, gathered at the Biomarker World Congress 2009 (May 27-29 in Philadelphia) to discuss the biomarker impact on Personalized Medicine, Clinical Pharmacology, Translational Medicine, Molecular Diagnostics, Safety Assessment, Clinical Trials, Assay Development, Go/No-Go Decision Making and Oncology in Drug & Diagnostics. The level of energy and participation reflected the booming interest in this field. Comprehensive Coverage of Biomarkers in: Personalized Medicine, Clinical Pharmacology, Translational Medicine, Molecular Diagnostics, Safety Assessment, Clinical Trials, Assay Development, Biomarker Qualification, Oncology Drugs & Diagnostics

This is the major international forum for the discussion of all technical aspects of scale-up at the chemistry/chemical engineering interface. Topics include: the scale up of batch and semi-batch processes, continuous processing and reaction engineering, microreactor technology, safety and thermochemistry, scale up of potentially hazardous chemistry, green chemistry, quality assurance and regulatory concerns, solid form control (crystallisation and polymorphism), separation and purification techniques, and new technologies and equipment for large scale manufacture.

Conference Programs Include: Phage and Yeast Display of Antibodies and Proteins, Engineering Antibodies, Antibody Optimization, Difficult to Express Proteins, Pre-Clinical/Clinical Development of Therapeutic Antibodies, Revival of Bispecific Antibodies: The Way Forward?, Immunogenicity of Therapeutic Biologics, Protein Aggregation in Biopharmaceutical Products, Bioanalytical Challenges for Optimizing Protein Therapeutics

Official Information: The 1st Annual World Congress of Catalytic Asymmetric Synthesis-2010 (WCCAS-2010) will be held from May 19 to May 21, 2010 in Beijing, China, with a theme of " Create Bioactive Molecules Green and Economically ". This is a focused event on Catalytic Asymmetric Synthesis, it aims to stimulate interactions among academia, industry and researchers in this field; to exchange up-to-the-minutes information and promote their novel technologies. On behalf of the organizing committee of WCCAS-2010, we cordially invite you to participate in this international event. Scope WCCAS-2010 is expected to greatly contribute to the promotion of new concepts for the development of efficient methodologies for catalytic asymmetric synthesis and its practical applications. The topics will reflect this general theme, placing emphasis on aspects that are common to all areas of catalytic asymmetric synthesis and the type of reaction involved: * Novel Technologies for Catalytic Asymmetric Synthesis * Organometallic Chiral Catalysts in Asymmetric Transformations * Enantioselective/ Diastereoselective Organocatalysis * Applications of Catalytic Asymmetric Synthesis * Biocatalysis for Asymmetric Transformations * Business Development for High Value Chiral Molecules Scientific Program The scientific program will consist of plenary and keynote lectures, approximately 30 sessions, exhibition and poster sessions. More program information can be found at: http://www.bitlifesciences.com/wccas2010/program.asp Location The capital city of the People's Republic of China, Beijing is a fast-growing, dynamic metropolis that, while courting foreign businesses and visitors, maintains a firm grip on its rich cultural heritage. Beijing made history in 2008 with the first Olympic Games ever to be held in China. The conference will be held in Beijing International Convention Center (BICC) which is located within the magnificent Asian Games Village. It is one of the Chinese biggest facilities specifically designed for conferences and exhibitions, comprising 50 conference halls and meeting rooms equipped to serve a wide variety of purposes with the capacity from 10 up to 2500 people. We look forward to seeing you in next May in Beijing, China.

The workshop will consist of lectures in the morning and applications of techniques and methodologies for the drug design in the afternoon (i.e. virtual screening, softwares for the synthesis, instrument description and exhibition, exercises etc). III EWDSy will feature more than 20 well known researchers from the University and from the Pharmaceutical Industry, including directors of research, working with a maximum number of 65 workshop participants. Some posters will be selected for a short presentation.

F-π-9 is expected to attract up to 500 participants from all over the world to discuss their new research and results in the context of conjugated polymer/oligomer synthesis, organic semiconductor materials, photovoltaic and electroactive materials and devices, graphene, functional π-systems for therapeutic applications and more. Six plenary speakers will present their latest research along with 35 invited speakers. The program will also include some 84 contributed talks and three poster sessions, which will allow students and others to highlight their recent work.

The biomedical industry is under enormous pressure to produce faster results, while also finding ways to reduce costs. Examples abound in one industry after another of how researchers have gained tremendous advantages by collaborating on pre-competitive efforts, but such efforts have been limited in biomedical research, where researchers often find it difficult to openly share data within their own organization, much less with competitors. Working together, sharing information, and data sets and costs, all have significant potential for improved performance, but only when such efforts make use of best practices and lessons learned from existing projects. Cambridge Healthtech Institute’s Collaborative Innovation in Biomedicine aims to bring together a number of experts with practical experience in organizing, managing, funding, and getting results from such projects. While there are real challenges with shared resources, IP protection, differing goals, and finding ways to equalize value contributions and benefits gains, some of the biggest challenges are based on firmly held beliefs about the risks of working together and narrow conceptions of what really constitute pre-competitive space. A key goal of the program is to provide attendees with a number of key strategies for identifying when and how collaborative innovation can and should be encouraged, as well as when such efforts are less likely to produce useful results.

Conference Program Include: Evaluating Novel Technologies for Cell Based Screening, Monitoring Cardiotoxicity and Drug Safety, Targeting Pain with Novel Therapeutics, New Tools for Detecting Nephrotoxicity, Successful Targeting of Alzheimer's Disease, Pharmacology Driven Assays for Current Targets, Integrated in vivo Molecular Imaging in Drug Discovery & Development, Early Assessments for Predicting Hepatotoxicity

There has been a significant increase in the level of activity and attention being paid to the development of therapeutics for neglected diseases over the past five years, but there are still considerable challenges in the road ahead. Diseases in the developed world receive a disproportional investment because of the commercial potential from large markets and the ability to pay for such treatment. Innovative approaches are being developed to stimulate interest and provide incentives for companies and other researchers to work on finding new therapeutics for diseases prevalent in developing countries. Almost all work in this field will be based on collaborations of one type or another, during discovery, drug evaluation or, when successful, delivery of treatments. This forum is designed to bring together many of the major stakeholders addressing these problems, in order to examine and discuss strategies and best practices for solving the major challenges that prevent faster and more effective solutions.

There has been a significant increase in the level of activity and attention being paid to the development of therapeutics for neglected diseases over the past five years, but there are still considerable challenges in the road ahead. Diseases in the developed world receive a disproportional investment because of the commercial potential from large markets and the ability to pay for such treatment. Innovative approaches are being developed to stimulate interest and provide incentives for companies and other researchers to work on finding new therapeutics for diseases prevalent in developing countries. Almost all work in this field will be based on collaborations of one type or another, during discovery, drug evaluation or, when successful, delivery of treatments. This forum is designed to bring together many of the major stakeholders addressing these problems, in order to examine and discuss strategies and best practices for solving the major challenges that prevent faster and more effective solutions.

17-18 June, 2010 House of Cybernetics, Tallinn, Estonia Intended Audience Engineers, technologists and scientists from glass industry and glass research laboratories who wish to acquire contemporary photoelastic methods for residual stress measurement in glass products of any shape. The participants may bring to Summer School samples they want to measure stresses in. Course Outline Basic elasticity, basic photoelasticity, integrated photoelasticity, stress field tomography, scattered light photoelasticity, automatic polariscope AP-07 for residual stress measurement in glass articles of complicated shape, scattered light polariscope SCALP-04 for thickness stress measurement in plates, immersion technique, software for stress calculation using measurement data, practical measurement of residual stress in tempered and annealed drinking glasses, bottles, CRT bulb panels and neck tubes, optical fibre performs, architectural glass panels and automotive glazing, etc.